首页> 美国卫生研究院文献>Translational Psychiatry >Subclinical hypothyroidism and depression: a meta-analysis
【2h】

Subclinical hypothyroidism and depression: a meta-analysis

机译:亚临床甲状腺功能减退症和抑郁症的荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The objective of this study was to evaluate the relationship between subclinical hypothyroidism (SCH) and depression. We also analysed the effect of levothyroxine (L-T4) on depression in SCH patients. We found an insignificant difference for the composite endpoint: standard mean difference (SMD) of 0.23 (95% confidence interval (CI) −0.03, 0.48, P = 0.08, I2 = 73.6%). The odds ratio (OR) for depressive patients was 1.75 (95% CI 0.97, 3.17 P = 0.064, I2 = 64.6%). Furthermore, sub-group analysis according to age found that SCH was related to depression in younger patients (<60 years old), as defined by the diagnosis of depression: OR of 3.8 (95% CI 1.02, 14.18, P = 0.047, I2 = 0.0%) or an increase on the depressive scale: SMD of 0.42 (95% CI 0.03, 0.82, P = 0.036, I2 = 66.6%). Meanwhile, SCH did not associate with depression in older patients (≥60 years old), as defined by the diagnosis of depression: OR of 1.53 (95% CI 0.81, 2.90, P = 0.193, I2 = 71.3%) or an increase on the depressive scale: SMD of 0.03 (95%CI −0.31, 0.37, P = 0.857, I2 = 79.8%). We also found an insignificant difference in the composite endpoint between the L-T4 supplementation group and placebo group in SCH patients. The estimated SMD was 0.26 (95% CI −0.09, 0.62, P = 0.143, I2 = 52.9%). This meta-analysis demonstrates that SCH is not connected to depression. However, sub-group analysis according to age found that SCH is related to depression in younger patients, but not in older patients. Furthermore, we failed to find an effect of L-T4 supplementation treatment for SCH on depression.
机译:这项研究的目的是评估亚临床甲状腺功能减退症(SCH)和抑郁症之间的关系。我们还分析了左甲状腺素(L-T4)对SCH患者抑郁的影响。我们发现复合终点的差异不明显:标准平均差异(SMD)为0.23(95%置信区间(CI)-0.03,0.48,P = 0.08,I 2 = 73.6%)。抑郁症患者的比值比(OR)为1.75(95%CI 0.97,3.17 P = 640.064,I 2 = 64.6%)。此外,根据年龄进行的亚组分析发现,根据抑郁症的诊断定义,SCH与年轻患者(<60岁)的抑郁症相关:OR为3.8(95%CI 1.02,14.18,P = 0.047,I 2 = 0.0%)或抑郁量表的增加:SMD为0.42(95%CI 0.03,0.82,P = 0.036,I 2 = 66.6%)。同时,根据抑郁症的诊断,SCH与老年患者(≥60岁)的抑郁症无关:OR为1.53(95%CI 0.81、2.90,P = 0.193,I 2 = 71.3%)或抑郁量表的增加:SMD为0.03(95%CI -0.31,0.37,P = 0.857,I 2 = 79.8%)。我们还发现SCH患者的L-T4补充组和安慰剂组在复合终点方面无显着差异。估计的SMD为0.26(95%CI -0.09,0.62,P = 0.143,I 2 = 52.9%)。这项荟萃分析表明,SCH与抑郁症没有关联。但是,根据年龄进行的亚组分析发现,SCH与年轻患者的抑郁症有关,而与老年患者无关。此外,我们没有找到补充L-T4的SCH治疗抑郁症的效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号